Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-055073

Chief Scientific Officer sold 22,200 shares at an average $51.86 ($1,151,338)

  • Chief Scientific Officer acquired 22,200 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-10-14 Option exercise +11,100 $6.32 $70,152 11,779 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-10-14 Sale −7,620 $51.87 $395,249 4,159 D: show line 2 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-10-14 Sale −3,480 $52.84 $183,883 679 D: show line 3 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-10-15 Option exercise +11,100 $6.32 $70,152 11,779 D: show line 4 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-10-15 Sale −11,100 $51.55 $572,205 679 D: show line 5 in the form
Open-market sales · 22,200 sh · avg $51.86 · $1,151,338

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-10-14 Option exercise · Stock Option (Right to Buy) −11,100 289,200 D: show line 6 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-10-15 Option exercise · Stock Option (Right to Buy) −11,100 278,100 D: show line 7 in the form
Loading xslF345X03/doc4.xml…